CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Cutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)
Authors
C. Biazar Sigges, J. Patsinakidis, N. Ruland, V. Amler, S. Bonsmann, G. Kuhn, A. Haust, M. Nyberg, F. Bata, Z. Mihályi, L. Olteanu, R. Pujol, R.M. Sánchez-Schmidt, J.M. Medenica, L. Skiljevic, D. Reich, A. Szepietowski, J.C. Dalle Vedove, C. Girolomoni, G. Hawro, T. Zalewska-Janowska, A. Glaeser, R. Huegel, R. Jedlicková, H. Bygum, A. Laurinaviciene, R. Benoit, S. Broecker, E. Bahmer, F.A. Aberer, E. Wutte, N. Lipozencic, J. Marinovic, B. Sárdy, M. Bekou, V. Ruzicka, T. Frances, C. Soutou, B. Lee, H. Worm, M. Gruschke, A. Hunzelmann, N. Steinbrink, K. Romiti, R. Sticherling, M. Erfurt-Berge, C. Avgerinou, G. Papafragkaki, D. Antiga, E. Caproni, M. Mayer, B. Volc-Platzer, B. Kreuter, A. Tigges, C. Heil, P.M. Stingl, G.
Publication date
1 January 2013
Publisher
Abstract
In this prospective, cross-sectional, multicenter study, we assessed clinical and laboratory characteristics from patients with cutaneous lupus erythematosus (CLE) using the Core Set Questionnaire of the European Society of Cutaneous Lupus Erythematosus (EUSCLE). 1002 (768 females, 234 males) patients with different subtypes of CLE, such as acute CLE (ACLE, 304 patients), subacute CLE (SCLE, 236 patients), chronic CLE (CCLE, 397 patients), and intermittent CLE (ICLE, 65 patients), from 13 European countries were collected and statistically analyzed by an SPSS database. The main outcome measures included gender, age at onset of disease, LE-specific and LE-nonspecific skin lesions, photosensitivity, laboratory features, and the criteria of the American College of Rheumatology (ACR) for the classification of systemic lupus erythematosus. The mean age at onset of disease was 43.0±15.7 years and differed significantly between the CLE subtypes. In 347 (34.6%) of the 1002 patients, two or more CLE subtypes were diagnosed during the course of the disease and 453 (45.2%) presented with LE-nonspecific manifestations. Drug-induced CLE and SjögrenD́s Syndrome had the highest prevalence in SCLE patients (13.1% and 14.0%, respectively). Photosensitivity was significantly more frequent in patients with ACLE, SCLE, and ICLE compared with those with CCLE. The detection of antinuclear antibodies such as anti-Ro/SSA and anti-La/SSB antibodies revealed further significant differences between the CLE subtypes. In summary, the EUSCLE Core Set Questionnaire and its database facilitate the analysis of clinical and laboratory features in a high number of patients with CLE and will contribute to standardized assessment and monitoring of the disease in Europe. © 2012 Elsevier B.V
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3004066
Last time updated on 10/02/2023